Drug Resistant Cells

Drug-resistant cell lines are indispensable tools for unraveling the mechanisms of chemotherapeutic resistance and developing strategies to overcome it in oncology research. By mimicking the adaptive responses of tumors to therapeutic pressure, these models enable the study of resistance pathways, biomarker discovery, and high-throughput drug screening.

Creative Bioarray offers a comprehensive collection of rigorously validated drug-resistant cell lines, developed through systematic exposure to escalating doses of chemotherapeutic agents. Each cell line is characterized for stability under consistent culturing conditions, ensuring reproducible performance in long-term experiments.

Highlights of Our Drug-Resistant Cell Lines

Stability: Guaranteed consistent resistance phenotypes across passages.

Comprehensive Biobanking: Diverse portfolio covering common and rare resistance profiles.

Custom Development: Tailored solutions for specific drugs, concentrations, or genetic backgrounds.

Description: EMT6/AR1 was derived from the mouse mammary tumour cell line EMT6/P by growth in increasing amounts ...

Cat#: CSC-C9497J INQUIRY

Description: The drug resistant cell line EMT6/AR10.0 was derived from the mouse mammary tumour cell line EMT6/P ...

Cat#: CSC-C9498J INQUIRY

Description: The cisplatin-resistant variant of the mouse mammary tumour cell line EMT6/P was derived by ...

Cat#: CSC-C9499J INQUIRY

Description: The drug-resistant cell line EMT6/MTXR was derived from the mouse mammary tumour cell line EMT6/P ...

Cat#: CSC-C9500J INQUIRY

Description: A mouse mammary cell line, EMT6/P is the parent cell line to a series of drug resistant lines also ...

Cat#: CSC-C9501J INQUIRY

Description: EMT6/VCR/R is a drug-resistant variant of the mouse mammary tumour cell line EMT6/P. It was derived ...

Cat#: CSC-C9502J INQUIRY

Description: The drug-resistant line EMT6/VRP/R was established from the parent cell line EMT6/P by growth in ...

Cat#: CSC-C9503J INQUIRY

Description: The drug resistant cell line K562 AZQ has been developed from the parent K562 cell line by ...

Cat#: CSC-C9504J INQUIRY

Description: This Adriamycin-resistant cell line has been developed by exposure of the parent L929 murine ...

Cat#: CSC-C9505J INQUIRY

Description: The MCF7/TAMR-7 Cell line is a breast cancer cell line resistant to tamoxifen. Tamoxifen is by far ...

Cat#: CSC-C9506J INQUIRY

Description: The multi drug-resistant cell line MES-SA/Dx5 was derived from the human uterine sarcoma cell line ...

Cat#: CSC-C9508J INQUIRY

Description: The drug resistant cell line MOR/0.2R has been derived from the parent line, MOR, by continuous ...

Cat#: CSC-C9510J INQUIRY

Description: MOR/0.4R has been developed from the parent line, MOR, by continuous exposure to increasing ...

Cat#: CSC-C9511J INQUIRY

Description: MOR/CPR has been developed by growing the parent line, MOR, in increasing concentrations of ...

Cat#: CSC-C9512J INQUIRY

Description: The cell line Pr8/22 has been derived from P388, a methylcholanthrene-induced lymphoid neoplasm ...

Cat#: CSC-C9518J INQUIRY

Description: The Exatecan-resistant cell line SKOV3/Exa was developed by repeatedly exposing the parental SKOV3 ...

Cat#: CSC-C9610L-Exa INQUIRY

For research use only. Not for any other purpose.